# Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT

> **NCT02872662** · — · COMPLETED · sponsor: **Nordic MDS Group** · enrollment: 308 (actual)

## Conditions studied

- MDS
- SCT
- MRD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02872662
- **Lead sponsor:** Nordic MDS Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2021-11-22
- **Final completion:** 2021-11-22
- **Target enrollment:** 308 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872662, "Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02872662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*